Dr. Pejman Ghanouni, MD, PhD

Dr. Ghanouni practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Ghanouni's NPI, 1124214028, was assigned on September 25, 2007. Dr. Ghanouni graduated from Stanford University School Of Medicine in 2005. Dr. Ghanouni's California license number on file is A96873.

Dr. Ghanouni's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Ghanouni's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. Dr. Ghanouni is also affiliated with Stanford Health Care Tri-Valley. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Ghanouni to 1 more hospital, named with a free account. Dr. Ghanouni's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ghanouni practices, 3 sites in all. Vendor and product names are available with a free account.

Diagnostic radiology is Dr. Ghanouni's primary specialty in the NPI Registry, under taxonomy code 2085R0202X. Dr. Ghanouni is board certified in diagnostic radiology by the American Board of Radiology. Dr. Ghanouni has a license on file in California.

CMS data shows 770 Medicare services from Dr. Ghanouni across 14 procedure codes in 2024, for 566 Medicare patients. Medicare paid $65,997 for them.

CMS counts 566 Medicare patients who saw Dr. Ghanouni in 2024. The largest group is 65 to 74, with 282 patients. 75% of them have high cholesterol, and 71% have high blood pressure. 23% are also on Medicaid. Their average risk score is 1.75, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ghanouni's median patient age at 59, with 43% women.

In 2024, Dr. Ghanouni wrote 82 Medicare Part D claims for 24 patients. 93% of them were for generic drugs. CMS names the drug for 51 of them, across 4 drugs with 11 or more claims each, at $771 in total drug cost. In 2023, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Ghanouni for performance year 2024, reported as part of a group. Dr. Ghanouni accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ghanouni as offering telehealth.

Dmand AI links 112 papers to Dr. Ghanouni, published from 2001 to 2025. 2022 was the busiest year, with 19. The most frequent topics are Magnetic Resonance Imaging, High-Intensity Focused Ultrasound Ablation and Prostatic Neoplasms. Dr. Ghanouni has published most often in Eur Radiol. Dr. Ghanouni's most frequent co-authors are Geoffrey Alexander Sonn, MD, Christian Anton Kunder, MD, PhD and Andrei Horia Iagaru, MD.

Dmand AI links Dr. Ghanouni to 5 clinical trials. Conditions studied include Cancer Pain, Essential Tremor and Leiomyoma. InSightec sponsors the most, 4.

CMS Open Payments shows 158 general payments to Dr. Ghanouni from 8 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 38% of the total. Insightec,inc paid the most, $31,589.

Dr. Ghanouni graduated from Stanford University School Of Medicine in 2005.

Dr. Ghanouni is in network with 3 carriers, including Excellus BlueCross BlueShield, CMS Medicare and NV State Medicaid. Medicare plans come from the most carriers, 2. Check the plan with the practice before a visit.